Axsome: Q2 Earnings Snapshot
By AP News
Published - Aug 05, 2024, 11:21 AM ET
Last Updated - Aug 05, 2024, 11:21 AM EDT
NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $79.3 million in its second quarter.
The New York-based company said it had a loss of $1.67 per share. Losses, adjusted for non-recurring costs, were $1.24 per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.30 per share.
The biopharmaceutical company posted revenue of $87.2 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $84.5 million.
